Member Info for Benharper

Is there to be a direct head to head trial in any of the forthcoming trials for AvA6000?

I’m under the impression time on drug and progression free survival are more than adequate. There’s 50 years of records of dox available. Ava6000 has a low bar to success as it only has to be as good as dox in efficacy, as side effects are already greatly reduced.

Thanks god the update, I’m having a chilli with tacos for dinner tonight

If you want to go down that route it’s more likely Fiona was given the boot not being an oncologist when and oncologists Christina walked in the room. A plausible deramp but Christina is qualified in the clinic Fiona isn’t, so any pivot would have probably happened when Fiona fu cked up not the other way round. Personally feel this is just as you said conspiracy clap trap.

It’s posters that get the SP moving, worked last time we were at these levels

The presentation in December covers this in detail, from 39 mins on I think

Three of a kind, not a bad hand just got to be careful of letting a flush or a straight in, so best not to slow play it. Twats that is.. Three twats

Paul Hill just knows Avacta have a big retail following so adds the hashtag and has AS on to boost his reach. Same goes less successfully for Charles Archer

Warning, avoid this thread. Better, more reliable and relevant info on a packet of custard creams.

To be fair they’ve said F all for a couple of weeks, whilst you just bleat on and on, I for one have got your point, now shall we see what they’ve got to say for themselves?

I’m up for hearing what they have to say, hurrying into sacking the CEO after so many years might be rash, personally I’m 50% down. But that shouldn’t affect the rationale of how to get out of this situation. Folk that think parachuting so and so out of of this, should be careful of what they wish for. Cool heads dudes

Ice cool is correct read the rns Derek. Your getting confused with the dose expansion which is the P1b for different indications

I’m not sure you’d fly all the way to the US and ask to be kicked in the knackers in front of the entire world oncology community, but on recent form…

I know trust is lost but the placing RNS says it’s Ava6000 P1a being presented at the conference.

You are spot on Bella, but we shouldered the risk for a few years and are rewarded with this. It’s a shi t show but it will recover.

No Derek, the release of the data at a highly regarded conference where all the industry are, is way more impactful. You could make an argument that the raise had to come so there’s money in the bank when the data is presented

Scuttling around on Twitter following anyone that follows these retail heavy stocks then pumping out drivel with a dose of told you so. Which he was undoubtedly told by some spiv a few days ago. Little smarmy low life grease ball, wannabe fin twist guru. C un t more like

The bus isn’t so bad Sheepy, you meet all walks of life, even mad bastards who tell you stories of blasting through the alps in supercars, I mean as if..

Charles Archer is an absolute Cun t. I only managed the first couple of sentences, what a flubbing knob

I had exactly same thought re CBO

Could a P2 run for sts, whilst a dose expansion ran for other indications? If that was the case it would make sense of the muddle.